Scarica l'app Stockscreener
22.28
8.79%
1.80
Dopo l'orario di chiusura:
22.00
-0.28
-1.26%
Sutro Biopharma Inc Borsa (STRO) Ultime notizie
Broker Revenue Forecasts For Sutro Biopharma, Inc. (NASDAQ:STRO) Are Surging Higher - simplywall.st
Sutro Biopharma, Inc. (NASDAQ:STRO) Just Reported And Analysts Have Been Lifting Their Price Targets - simplywall.st
Sutro Biopharma, Inc. (NASDAQ:STRO) Given Average Rating of "Buy" by Analysts - MarketBeat
Sutro Biopharma (STRO): Perceptive Advisors reports 7.9% beneficial stake - Stock Titan
Sutro Biopharma (STRO): Point72 group reports 1.4% stake in 13G/A - Stock Titan
Sutro Biopharma Q3 EPS Forecast Reduced by HC Wainwright - MarketBeat
STRO Maintained by Citizens -- Price Target Lowered to $34.00 - GuruFocus
Sutro Biopharma (NASDAQ:STRO) Price Target Lowered to $34.00 at Citizens Jmp - MarketBeat
STRO Reiterated by Wedbush -- Price Target Maintained at $60 - GuruFocus
Sutro Biopharma (NASDAQ:STRO) Earns Outperform Rating from Wedbush - MarketBeat
Citizens cuts Sutro Biopharma stock price target on revenue miss - Investing.com
Citizens cuts Sutro Biopharma stock price target on revenue miss By Investing.com - Investing.com Canada
Sutro Biopharma earnings missed by $0.13, revenue fell short of estimates - Investing.com Canada
Is Sutro Biopharma Inc (STRO) Facing Pressures After Q2 Earnings - GuruFocus
Sutro Biopharma Releases Q2 2026 Financial Results - AlphaStreet
Why is Sutro Biopharma Stock Falling On Wednesday? - TradingView
Sutro Biopharma (NASDAQ:STRO) Posts Quarterly Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat
Sutro Biopharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Sutro Biopharma Reports Q2 2026 Financial Results and Pipeline Update - Kalkine Media
Sutro Biopharma Announces Q2 2026 Financial Results and Updates Corporate Presentation - Kalkine Media
Form 8K Sutro Biopharma For: 12 August By Investing.com - Investing.com Nigeria
Sutro Biopharma Q2 Results Highlight Advancing ADC Pipeline - TipRanks
Sutro reports early clinical responses from STRO-004 cancer trial By Investing.com - Investing.com Australia
SUTRO BIOPHARMA, INC. 2Q 2026: Revenue $9.84M, EPS ($2.33) — 10-Q Summary - TradingView
Sutro Biopharma (STRO) revenue drops as cash rises after $110M stock sale - Stock Titan
Sutro Biopharma Reports $9.8 Million Revenue in Q2 2026 - Quiver Quantitative
Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study - The Manila Times
Sutro Biopharma delivers Q2 2026 financials and advances Phase 1 STRO-004 trial - Traders Union
Sutro Biopharma (STRO) Earnings Date and Reports 2026 $STRO - MarketBeat
Sutro Biopharma (STRO) Edges Higher to $25.53 as Traders Eye Key Resistance at $26.81Stock News - dars.gov.et
Stifel Initiates Sutro Biopharma(STRO.US) With Buy Rating, Announces Target Price $48 - moomoo.com
Sutro Biopharma (STRO) Institutional Ownership 2026 $STRO - MarketBeat
SUTRO BIOPHARMA INC : STIFEL INITIATES COVERAGE WITH BUY RATING; PRICE TARGET $48 - Bitget
Stifel initiates Sutro Biopharma stock with buy on ADC platform By Investing.com - Investing.com Australia
Stifel initiates Sutro Biopharma stock with buy on ADC platform - Investing.com
BlackRock, Inc. Adds to Sutro Biopharma Inc (STRO) Stake -- Shar - GuruFocus
Perceptive Advisors LLC Invests $17.82 Million in Sutro Biopharma, Inc. $STRO - MarketBeat
Sutro Biopharma Inc (STRO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BlackRock, Inc. (NASDAQ: STRO) reports 6.4% ownership in Sutro Biopharma - Stock Titan
Sutro Biopharma (STRO) Surges as Volume Supports Bullish MomentumHigh Conviction Picks - dars.gov.et
ADAR1 Capital Management LLC Purchases 457,364 Shares of Sutro Biopharma, Inc. $STRO - MarketBeat
Eversept Partners LP Trims Stake in Sutro Biopharma, Inc. $STRO - MarketBeat
Sutro Biopharma Inc (STRO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sutro Biopharma (STRO) Climbs 5.24% as Biotech Sentiment ImprovesTake Profit Levels - po-news-eg.net
STRO|Sutro Biopharma Inc|Price:23.918|Chg%:+1.038 - TradingKey
STRO|Sutro Biopharma Inc|Price:24.170|Chg%:-0.650 - TradingKey
Sutro Biopharma Inc (STRO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sutro Biopharma Inc (STRO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sutro Biopharma Inc (STRO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Orbimed Advisors LLC Purchases New Position in Sutro Biopharma, Inc. $STRO - MarketBeat
Sutro Biopharma Inc (STRO) Institutional Confidence - TradingKey
Sutro Biopharma Inc (STRO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sutro Biopharma Inc (STRO) Cash Flow - TradingKey
Affinity Asset Advisors LLC Grows Stock Holdings in Sutro Biopharma, Inc. $STRO - MarketBeat
Sutro Biopharma Inc (STRO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sutro Biopharma, Inc. Common Stock (STRO) Stock Price Today: $26.03 - Gotrade
Sutro Biopharma (STRO) TD Cowen 46th Annual Health Care Conference Summary - Quartr
Sutro Biopharma (STRO) 2024 Wells Fargo Healthcare Conference Summary - Quartr
Enterprise value to EBITDA forward of Sutro Biopharma, Inc. – NASDAQ:STRO - TradingView
Price to sales forward of Sutro Biopharma, Inc. – NASDAQ:STRO - TradingView
Enterprise value to EBIT forward of Sutro Biopharma, Inc. – NASDAQ:STRO - TradingView
Price to earnings forward of Sutro Biopharma, Inc. – NASDAQ:STRO - TradingView
Price to book forward of Sutro Biopharma, Inc. – NASDAQ:STRO - TradingView
Sutro Biopharma (STRO) price target increased by 13.85% to 37.74 - MSN
Sutro Biopharma, Inc.(NasdaqGM:STRO) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
1.80%
1.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):